Radiotherapy Devices Market By Technology, Applications & Products (2011 – 2016)

“Radiotherapy Devices Market By Technology, Applications & Products (2011 – 2016) (Cyberknife, Gammaknife, Linac, Tomotherapy, Proton Therapy Systems, Seeds, Afterloaders, Iodine-131, IMRT, IGRT, Volumetric Modulated Arc Therapy & Stereotactic Technology) - Global Trends & Competitive Analysis”

Radiotherapy refers to the therapeutic procedures using high energy electromagnetic waves or radioactive particulates to thwart abnormal cell growths within our body system and repair different physiological abnormalities. This report analyzes the market potential for devices used in radiotherapies for different body systems. This device market encompasses devices for external beam radiation therapy (CyberKnife, Gamma Knife, electron emitting high energy linear accelerators, proton therapy machines etc), brachytherapy (seeds, applicators-afterloaders, and electronic brachytherapy) and systemic radiation therapy (Iodine-131, Samarium-153, Rhenium-186, Erbium-169, etc.).

The global radiotherapy devices market, consisting of devices used in both systemic and blood-borne oncology treatment procedures, was valued at $4.4 billion in 2011 and is expected to reach $5.8 billion by 2016, at a CAGR of 5.3% from 2011 to 2016. External beam therapy devices contribute the maximum share (81.5%) to the global radiotherapy devices market, followed by internal radiotherapy devices (9.6%) and systemic radiotherapy devices (8.9%).

The major driving factor for these markets involves reimbursement support to the radiotherapy procedures in the developed countries over conventional therapeutic procedures. As the incidence cases of cancer diseases continue to rise in the coming years, along with increasing trends in accurate diagnosis and precise treatment planning system, the radiotherapy devices market for treating these diseases would show significant growth in the forecast period.

The external beam radiation therapy in radio-oncology represents the largest segment of the market. In the global radiotherapy market, the linear accelerator devices market contributed the largest share (65%) of the total market with $2.8 billion in 2011 and is expected to reach $3.7 billion by 2016. The key driving factor for this market would be the increased usage of these devices due to significant technological revolution and its capability to provide better and precise treatment services.

North America is the biggest market for vascular interventional devices, followed by Europe. However, Asian countries represent the most promising and fastest growing markets as low procedural and infrastructural costs have led to an increased drive of patients from developed regions towards Asian countries such as India and China.

Major players in the market include Varian Medical System (U.S.), Elekta AB (Sweden) and Accuray (U.S.), IBA Group (Belgium), Eckert & Ziegler BEBIG (Belgium), iCAD, Inc. (U.S.), GE Healthcare (U.K.), Covidien, PLC (Ireland), C.R. Bard, Inc. (U.S.), Nordion, Inc. (Canada), Theragenics Corporation (U.S.), Oncura, Inc. (U.S.) among others.

Table Of Contents



TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Rapidly changing cancer treatment technology forces continual innovation
3.3.1.2 Healthy reimbursement plans are facilitating the growth in developed countries
3.3.1.3 Untapped markets in the emerging countries are pushing up market growth
3.3.1.4 Cost-effective and precise treatment procedure is alluring more market penetration
3.3.1.5 Growing number of cancer patients is pulling up market demand
3.3.2 RESTRAINTS
3.3.2.1 Alternative treatment procedure hinders the radiotherapy growth
3.3.2.2 Lack of adequate infrastructure and healthcare expenditure restrict the market growth
3.3.2.3 Lack of adequate skills and training is limiting the radiotherapy growth
3.3.3 THREATS and OPPORTUNITIES
3.4 TRENDS
3.5 MARKET SHARE ANALYSIS OF MAJOR PLAYERS

4 GLOBAL RADIOTHERAPY DEVICES MARKET, BY PRODUCTS (VALUE and VOLUME ANALYSIS)
4.1 INTRODUCTION
4.2 EXTERNAL BEAM RADIATION THERAPY
4.2.1 INTRODUCTION
4.2.2 COMPACT ADVANCED RADIOTHERAPY SYSTEMS
4.2.2.1 CyberKnife
4.2.2.2 Gamma Knife
4.2.2.3 TomoTherapy
4.2.3 PROTON THERAPY SYSTEMS
4.2.3.1 Cyclotron
4.2.3.2 Synchrotron
4.2.4 ELECTRON EMITTING HIGH ENERGY LINEAR ACCELERATORS (LINAC)
4.3 INTERNAL RADIATION THERAPY/BRACHYTHERAPY
4.3.1 SEEDS
4.3.2 APPLICATORS and AFTERLOADERS
4.3.3 ELECTRONIC BRACHYTHERAPY
4.4 SYSTEMIC RADIATION THERAPY
4.4.1 INTRODUCTION
4.4.2 IOBENGUANE (I-131)
4.4.3 RHENIUM (RE-186)
4.4.4 SAMARIUM (SM-153)
4.4.5 ERBIUM (ER-169)
4.4.6 YTTRIUM-90 (Y-90)

5 GLOBAL RADIOTHERAPY DEVICES MARKET, BY APPLICATIONS (VALUE ANALYSIS)
5.1 INTRODUCTION
5.2 GLOBAL EXTERNAL BEAM RADIATION THERAPY
5.2.1 PROSTATE CANCER
5.2.2 BREAST CANCER
5.2.3 LUNG CANCER
5.2.4 HEAD and NECK CANCER
5.2.5 COLORECTAL CANCER
5.2.6 SPINE CANCER
5.2.7 NEUROSURGERY and BRAIN CANCER
5.3 GLOBAL INTERNAL RADIATION THERAPY
5.3.1 PROSTATE CANCER
5.3.2 GYNECOLOGICAL CANCER
5.3.3 BREAST CANCER
5.3.4 CERVICAL CANCER
5.3.5 PENILE CANCER
5.3.6 LUNG CANCER
5.3.7 HEAD and NECK CANCER
5.3.8 ESOPHAGEAL CANCER
5.4 GLOBAL SYSTEMIC RADIATION THERAPY

6 GLOBAL RADIOTHERAPY DEVICES MARKET, BY TECHNOLOGY (VALUE ANALYSIS)
6.1 INTRODUCTION
6.2 EXTERNAL BEAM RADIATION THERAPY
6.2.1 INTENSITY MODULATED RADIATION THERAPY (IMRT)
6.2.2 IMAGE GUIDED RADIO THERAPY (IGRT)
6.2.3 TOMOTHERAPY
6.2.4 STEREOTACTIC TECHNOLOGY
6.2.5 3-D CONFORMAL RADIOTHERAPY
6.2.6 PROTON BEAM THERAPY
6.2.7 VOLUMETRIC MODULATED ARC THERAPY
6.2.8 ADAPTIVE RADIATION THERAPY
6.3 INTERNAL BEAM RADIOTHERAPY
6.3.1 LOW DOSE RATE
6.3.2 HIGH DOSE RATE
6.4 SYSTEMIC RADIATION THERAPY
6.4.1 INTRODUCTION
6.4.2 ROUTE OF ADMINISTRATION
6.4.2.1 Intravenous administration
6.4.2.2 Oral administration

7 GEOGRAPHIC ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.3 EUROPE
7.4 ASIA
7.5 ROW

8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 MERGERS and ACQUISITIONS
8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES
8.4 NEW PRODUCTS LAUNCH
8.5 APPROVALS
8.6 EXPANSIONS
8.7 OTHER DEVELOPMENTS

9 COMPANY PROFILE
9.1 ACCURAY, INC.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCTS and SERVICES
9.1.4 STRATEGY
9.1.5 DEVELOPMENTS
9.2 ANGIODYNAMICS, INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCTS and SERVICES
9.2.4 STRATEGY
9.2.5 DEVELOPMENTS
9.3 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANIZATION (ANSTO)
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCTS and SERVICES
9.3.4 STRATEGY
9.3.5 DEVELOPMENTS
9.4 BOARD OF RADIATION AND ISOTOPE TECHNOLOGY (BRIT)
9.4.1 OVERVIEW
9.4.2 PRODUCTS and SERVICES
9.4.3 STRATEGY
9.5 BOSTON SCIENTIFIC CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCTS and SERVICES
9.5.4 STRATEGY
9.5.5 DEVELOPMENTS
9.6 C. R. BARD, INC.
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCTS and SERVICES
9.6.4 STRATEGY
9.7 CARDINAL HEALTH, INC.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCTS and SERVICES
9.7.4 STRATEGY
9.7.5 DEVELOPMENTS
9.8 CARL ZEISS AG
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCTS and SERVICES
9.8.4 STRATEGY
9.8.5 DEVELOPMENTS
9.9 COVIDIEN, PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCTS and SERVICES
9.9.4 STRATEGY
9.9.5 DEVELOPMENTS
9.10 ECKERT and ZIEGLER BEBIG S.A.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCTS and SERVICES
9.10.4 STRATEGY
9.10.5 DEVELOPMENTS
9.11 ECZACIBA?I -MONROL
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCTS and SERVICES
9.11.4 STRATEGY
9.11.5 DEVELOPMENTS
9.12 ELEKTA AB
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCTS and SERVICES
9.12.4 STRATEGY
9.12.5 DEVELOPMENTS
9.13 GE HEALTHCARE
9.13.1 OVERVIEW
9.13.2 FINANCIALS
9.13.3 PRODUCTS and SERVICES
9.13.4 STRATEGY
9.13.5 DEVELOPMENTS
9.14 IBA GROUP
9.14.1 OVERVIEW
9.14.2 FINANCIALS
9.14.3 PRODUCTS and SERVICES
9.14.4 STRATEGY
9.14.5 DEVELOPMENTS
9.15 ICAD, INC.
9.15.1 OVERVIEW
9.15.2 FINANCIALS
9.15.3 PRODUCTS and SERVICES
9.15.4 STRATEGY
9.15.5 DEVELOPMENTS
9.16 INSTITUTE OF ATOMIC ENERGY POLATOM RADIOISOTOPE CENTRE (POLATOM)
9.16.1 OVERVIEW
9.16.2 PRODUCTS and SERVICES
9.16.3 STRATEGY
9.16.4 DEVELOPMENTS
9.17 INSTITUTE OF ISOTOPES CO. LTD.
9.17.1 OVERVIEW
9.17.2 PRODUCTS and SERVICES
9.17.3 STRATEGY
9.18 ISORAY MEDICAL, INC.
9.18.1 OVERVIEW
9.18.2 FINANCIALS
9.18.3 PRODUCTS and SERVICES
9.18.4 STRATEGY
9.18.5 DEVELOPMENTS
9.19 NORDION, INC
9.19.1 OVERVIEW
9.19.2 FINANCIALS
9.19.3 PRODUCTS and SERVICES
9.19.4 STRATEGY
9.19.5 DEVELOPMENTS
9.20 PROTOM INTERNATIONAL, INC.
9.20.1 OVERVIEW
9.20.2 FINANCIALS
9.20.3 PRODUCTS and SERVICES
9.20.4 STRATEGY
9.20.5 DEVELOPMENTS
9.21 SIEMENS HEALTHCARE
9.21.1 OVERVIEW
9.21.2 FINANCIALS
9.21.3 PRODUCTS and SERVICES
9.21.4 STRATEGY
9.21.5 DEVELOPMENTS
9.22 THERAGENICS CORPORATION
9.22.1 OVERVIEW
9.22.2 FINANCIALS
9.22.3 PRODUCTS and SERVICES
9.22.4 STRATEGY
9.22.5 DEVELOPMENTS
9.23 VARIAN MEDICAL SYSTEMS, INC.
9.23.1 OVERVIEW
9.23.2 FINANCIALS
9.23.3 PRODUCTS and SERVICES
9.23.4 STRATEGY
9.23.5 DEVELOPMENTS


LIST OF TABLES

TABLE 1 GLOBAL RADIOTHERAPY DEVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 2 RADIOTHERAPY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 3 GLOBAL EXTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 4 EXTERNAL BEAM THERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 5 GLOBAL COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 6 CYBERKNIFE SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 7 CYBERKNIFE SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (NO. OF UNITS)
TABLE 8 COMPARISON BETWEEN CYBERKNIFE, GAMMA KNIFE and OTHER LINIAC SYSTEMS
TABLE 9 GAMMA KNIFE SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 10 GAMMA KNIFE SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (NO. OF UNITS)
TABLE 11 TOMOTHERAPY SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 12 TOMOTHERAPY SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (NO. OF UNITS)
TABLE 13 GLOBAL PROTON THERAPY SYSTEMS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 14 PROTON THERAPY SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 15 ELECTRON EMITTING HIGH ENERGY LINEAR ACCELERATORS (LINAC) SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 16 ELECTRON EMITTING HIGH ENERGY LINEAR ACCELERATORS (LINAC) SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (NO. OF UNITS)
TABLE 17 GLOBAL INTERNAL BEAM/BRACHYTHERAPY MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 18 INTERNAL BEAM/BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 19 GLOBAL BRACHYTHERAPY SEEDS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 20 BRACHYTHERAPY SEEDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 21 CESIUM-131 BRACHYTHERAPY SEEDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 22 IODINE-125 BRACHYTHERAPY SEEDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 23 PALLADIUM-103 BRACHYTHERAPY SEEDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 24 IRIDIUM-192 BRACHYTHERAPY SEEDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 25 OTHER BRACHYTHERAPY SEEDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 26 GLOBAL BRACHYTHERAPY SEEDS MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 27 BRACHYTHERAPY SEEDS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 28 CESIUM-131 BRACHYTHERAPY SEEDS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 29 IODINE-125 BRACHYTHERAPY SEEDS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 30 PALLADIUM-103 BRACHYTHERAPY SEEDS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 31 IRIDIUM-192 BRACHYTHERAPY SEEDS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 32 OTHER BRACHYTHERAPY SEEDS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 33 APPLICATORS and AFTERLOADERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 34 GLOBAL SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 35 SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 36 IODINE-131 RADIOISOTOPE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 37 RHENIUM-186 RADIOISOTOPE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 38 SAMARIUM-153 RADIOISOTOPE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 39 ERBIUM-169 RADIOISOTOPE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 40 YTTRIUM-90 RADIOISOTOPE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 41 OTHER RADIOISOTOPES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 42 GLOBAL EXTERNAL BEAM THERAPY MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 43 GLOBAL INTERNAL BEAM THERAPY MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 44 GLOBAL EXTERNAL BEAM THERAPY MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 45 COMPARATIVE BETWEEN TOMOTHERAPY and CONVENTIONAL TREATMENT
TABLE 46 GLOBAL INTERNAL BEAM THERAPY MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
TABLE 47 NORTH AMERICA: RADIOTHERAPY DEVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 48 NORTH AMERICA: EXTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 49 NORTH AMERICA: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 50 NORTH AMERICA: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET VOLUME, BY SEGMENTS, 2009 - 2016 (NO. OF UNITS)
TABLE 51 NORTH AMERICA: INTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 52 NORTH AMERICA: SEEDS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 53 NORTH AMERICA: SEEDS MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (NO. OF UNITS)
TABLE 54 NORTH AMERICA: SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 55 EUROPE: RADIOTHERAPY DEVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 56 EUROPE: EXTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 57 EUROPE: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 58 EUROPE: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET VOLUME, BY SEGMENTS, 2009 - 2016 (NO. OF UNITS)
TABLE 59 EUROPE: INTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 60 EUROPE: SEEDS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 (NO. OF UNITS)
TABLE 61 EUROPE: SEEDS MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (NO. OF UNITS)
TABLE 62 EUROPE: SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 63 ASIA: RADIOTHERAPY DEVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 64 ASIA: EXTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 65 ASIA: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 66 ASIA: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET VOLUME, BY SEGMENTS, 2009 - 2016 (NO. OF UNITS)
TABLE 67 ASIA: INTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 68 ASIA: SEEDS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 69 ASIA: SEEDS MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (NO. OF UNITS)
TABLE 70 ASIA: SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 71 ROW: RADIOTHERAPY DEVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 72 ROW: EXTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 73 ROW: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 74 ROW: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET VOLUME, BY SEGMENTS, 2009 - 2016 (NO. OF UNITS)
TABLE 75 ROW: INTERNAL BEAM THERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
TABLE 76 ROW: SEEDS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 77 ROW: SEEDS MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (NO. OF UNITS)
TABLE 78 ROW: SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 79 MERGERS and ACQUISITIONS, 2009 - 2012
TABLE 80 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES, 2009 - 2012
TABLE 81 NEW PRODUCTS LAUNCH, 2009 - 2012
TABLE 82 APPROVALS, 2009 - 2012
TABLE 83 EXPANSIONS, 2009 -2012
TABLE 84 OTHER DEVELOPMENTS, 2009 - 2012
TABLE 85 ACCURAY, INC.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 86 ACCURAY, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 87 ACCURAY, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 88 ANGIODYNAMICS, INC.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 201 ($MILLION)
TABLE 89 ANGIODYNAMICS, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 90 ANGIODYNAMICS, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 91 ANSTO: TOTAL REVENUE OF RADIOISOTOPES, 2009 - 2011 ($MILLION)
TABLE 92 BOSTON SCIENTIFIC CORP.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 93 BOSTON SCIENTIFIC CORP.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 94 BOSTON SCIENTIFIC CORP.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 95 C. R. BARD, INC.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 96 C. R. BARD, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 97 C. R. BARD, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 (MILLION)
TABLE 98 CARDINAL HEALTH, INC.: TOTAL REVENUE , 2009 - 2011 ($MILLION)
TABLE 99 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 100 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 101 CARL ZEISS AG: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 102 CARL ZEISS AG: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 103 CARL ZEISS AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 104 COVIDIEN, PLC.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 105 COVIDIEN, PLC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 106 COVIDIEN, PLC: RADIOPHARMACEUTICALS REVENUE, 2009 - 2011 ($MILLION)
TABLE 107 COVIDIEN, PLC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 108 ECKERT and ZIEGLER BEBIG S.A.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 109 ECKERT and ZIEGLER BEBIG S.A.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 110 ELEKTA AB: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 111 ELEKTA AB: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 112 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 113 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 114 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 115 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 116 IBA GROUP: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 117 IBA GROUP: TOTAL MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 118 IBA GROUP: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 119 ICAD, INC.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 120 ICAD INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($ MILLION)
TABLE 121 ISORAY MEDICAL, INC.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011($MILLION)
TABLE 122 NORDION: MARKET REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 123 NORDION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 124 NORDION: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 125 SIEMENS AG: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 126 SIEMENS AG: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 127 SIEMENS AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 128 THERAGENICS CORP.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 129 THERAGENICS CORP.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 130 THERAGENICS CORP.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 131 VARIAN MEDICAL SYSTEMS, INC.: TOTAL REVENUE AND RandD EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 132 VARIAN MEDICAL SYSTEMS, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 133 VARIAN MEDICAL SYSTEMS, INC.: ONCOLOGY SYSTEM and X-RAY PRODUCTS, BY GEOGRAPHY, 2009 - 2011 ($MILLION)


LIST OF FIGURES


FIGURE 1 TRENDS IN RADIOTHERAPY MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
FIGURE 2 RADIOTHERAPY MARKET REVENUE, BY GEOGRAPHY
FIGURE 3 GLOBAL RADIOTHERAPY DEVICES MARKET SEGMENTATION
FIGURE 4 MARKET DYNAMICS
FIGURE 5 GLOBAL RADIOTHERAPY MARKET SHARE, BY PLAYERS, 2011
FIGURE 6 GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET SHARE, BY PLAYERS, 2011
FIGURE 7 INTERNAL BEAM RADIOTHERAPY MARKET SHARE, BY PLAYERS, 2011
FIGURE 8 SYSTEMIC RADIATION THERAPY MARKET SHARE, BY PLAYERS, 2011
FIGURE 9 VARIOUS STEPS IN EXTERNAL BEAM RADIATION TREATMENT PROCESS
FIGURE 10 BUBBLE CHART: EXTERNAL BEAM RADIATION THERAPY DEVICES MARKET
FIGURE 11 COMPACT ADVANCED RADIOTHERAPY SYSTEMS
FIGURE 12 CYBERKNIFE MARKET, BY VOLUME (NO. OF INSTALLATION UNITS), 2009 - 2016
FIGURE 13 CYBERKNIFE MARKET ANALYSIS, BY VOLUME and VALUE, 2009 - 2016
FIGURE 14 GAMMAKNIFE MARKET, BY VOLUME (NO. OF INSTALLATION UNITS), 2009 - 2016
FIGURE 15 GAMMA KNIFE MARKET ANALYSIS, BY VOLUME and VALUE, 2009 - 2016
FIGURE 16 VARIOUS STEPS OF THE HELICAL TOMOTHERAPY PROCESS
FIGURE 17 TOMOTHERAPY MARKET, BY VOLUME (NO. OF INSTALLATION UNITS), 2009 - 2016
FIGURE 18 TOMOTHERAPY MARKET ANALYSIS, BY VOLUME and VALUE, 2009 - 2016
FIGURE 19 PROTON THERAPY SYSTEM
FIGURE 20 EVOLUTION OF ACCELERATORS
FIGURE 21 MECHANISM IN LINEAR ACCELERATOR SYSTEM
FIGURE 22 LINAC MARKET ANALYSIS, BY VOLUME and VALUE, 2009 - 2016
FIGURE 23 INTERNAL RADIOTHERAPY SYSTEM
FIGURE 24 SEEDS MARKET ANALYSIS, BY VOLUME and VALUE, 2009 - 2016
FIGURE 25 GLOBAL RADIOTHERAPY MARKET REVENUE, BY APPLICATIONS, 2009 - 2016
FIGURE 26 GLOBAL EBRT MARKET SHARE, BY APPLICATIONS, 2011
FIGURE 27 INTERNAL BEAM RADIOTHERAPY TREATMENT PROCESS
FIGURE 28 GLOBAL IBRT MARKET SHARE, BY APPLICATIONS, 2011
FIGURE 29 TECHNOLOGICAL EVOLUTION IN RADIOTHERAPY MARKET
FIGURE 30 GLOBAL RADIOTHERAPY MARKET REVENUE, BY TECHNOLOGY, 2011
FIGURE 31 GLOBAL EBRT MARKET REVENUE, BY TECHNOLOGY, 2011 and 2016 ($MILLION)
FIGURE 32 VARIOUS STEPS IN IGRT MECHANISM
FIGURE 33 VARIOUS STEPS IN 3-D CRT MECHANISM
FIGURE 34 ADAPTIVE RADIOTHERAPY TREATMENT CHAIN
FIGURE 35 EBRT MARKET, BY GEOGRAPHY, 2011 ($MILLION)
FIGURE 36 NORTH AMERICA: RADIOTHERAPY MARKET SHARE, 2011 and 2016
FIGURE 37 EUROPE: RADIOTHERAPY MARKET SHARE, 2011 and 2016
FIGURE 38 ASIA: RADIOTHERAPY MARKET SHARE, 2011 and 2016
FIGURE 39 ROW INCLUDING JAPAN: RADIOTHERAPY MARKET SHARE, 2011 - 2016
FIGURE 40 KEY GROWTH STRATEGIES, JANUARY 2009 - MAY 2012

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Photomedicine: Technologies and Global Markets

Photomedicine: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research study provides a comprehensive analysis of the market of photomedicine. It addresses the drivers and limiters of the market and offers an exhaustive analysis of both drugs and medical ...

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary GBI Research has released the pharma report, “ADHD Therapeutics ...

Hospital Infection Therapeutics Market (Drug Type: Antibacterial, Antiviral and Antifungal Drugs; Infection Type) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Hospital Infection Therapeutics Market (Drug Type: Antibacterial, Antiviral and Antifungal Drugs; Infection Type) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • $ 4 795
  • Industry report
  • September 2014
  • by Transparency Market Research

Hospital Infection Therapeutics Market (Drug Type: Antibacterial, Antiviral and Antifungal Drugs; Infection Type: Hospital-Acquired Pneumonia, Urinary Tract Infections, Gastrointestinal Disorders, Bloodstream ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.